KILITCH DRUGS (INDIA)
Back to Cashflow Statement
|
KILITCH DRUGS (INDIA) Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹18 Cr | ₹-1.53 Cr | ₹2.59 Cr | ₹5.78 Cr | ₹46 Cr |
What is the latest Cash Flow from Operating Activities ratio of KILITCH DRUGS (INDIA) ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹18 Cr |
| Mar2024 | ₹-1.53 Cr |
| Mar2023 | ₹2.59 Cr |
| Mar2022 | ₹5.78 Cr |
| Mar2021 | ₹46 Cr |
How is Cash Flow from Operating Activities of KILITCH DRUGS (INDIA) Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹18 Cr | Positive | |
| Mar2024 | ₹-1.53 Cr | Negative | |
| Mar2023 | ₹2.59 Cr | -55.28 | |
| Mar2022 | ₹5.78 Cr | -87.33 | |
| Mar2021 | ₹46 Cr | - | |
Compare Cash Flow from Operating Activities of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹629.7 Cr | -4.6% | 0.8% | -16.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,644.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹184,053.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹167,464.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹115,263.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,049.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | -4.6% |
0.8% |
-16.3% |
| SENSEX | -0.9% |
4.9% |
-6.8% |
You may also like the below Video Courses